R. Beegan

Experimental rhinovirus 16 infection in moderate asthmatics on inhaled corticosteroids

S. Johnston, R. Djukanović, J. Gern, 2013, European Respiratory Journal.

Safety and efficacy of inhaled nebulised interferon beta-1a (SNG001) for treatment of SARS-CoV-2 infection: a randomised, double-blind, placebo-controlled, phase 2 trial

Dave Singh, R. Djukanović, S. Holgate, 2020, The Lancet Respiratory Medicine.

Effect of inhaled SNG001 (interferon-beta 1a) on sputum and blood antiviral biomarkers following a respiratory virus infection in asthmatic subjects

S. Hrebien, C. Boxall, K. Lunn, 2013 .